88 related articles for article (PubMed ID: 22002443)
1. The Caenorhabditis elegans K10C2.4 gene encodes a member of the fumarylacetoacetate hydrolase family: a Caenorhabditis elegans model of type I tyrosinemia.
Fisher AL; Page KE; Lithgow GJ; Nash L
J Biol Chem; 2008 Apr; 283(14):9127-35. PubMed ID: 18227072
[TBL] [Abstract][Full Text] [Related]
2. A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I.
Balestra D; Scalet D; Ferrarese M; Lombardi S; Ziliotto N; C Croes C; Petersen N; Bosma P; Riccardi F; Pagani F; Pinotti M; van de Graaf SFJ
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244944
[TBL] [Abstract][Full Text] [Related]
3. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1.
Dweikat I; Qawasmi N; Najeeb A; Radwan M
Metabol Open; 2021 Mar; 9():100083. PubMed ID: 33598652
[TBL] [Abstract][Full Text] [Related]
5. Novel HPD mutation p.A244V compound with p.T219M causing tyrosinemia type III in a Chinese girl and review of the genotype-phenotype spectrum.
Han D; Wang L; Zhao C; Li J; Huang C; Song W; Wang H; Li X; Tao Y
Mol Genet Genomic Med; 2024 Jan; 12(1):e2298. PubMed ID: 37817461
[TBL] [Abstract][Full Text] [Related]
6. Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children.
Khan SA; Fakih M; Taufiq N; Ahmerin A; Bangash A; Iqbal Malik M
Clin Med Insights Pediatr; 2024; 18():11795565241236176. PubMed ID: 38456192
[TBL] [Abstract][Full Text] [Related]
7. Multiple mutations and cancer.
Loeb LA; Loeb KR; Anderson JP
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):776-81. PubMed ID: 12552134
[TBL] [Abstract][Full Text] [Related]
8. Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes.
Liu Q; Thorland EC; Heit JA; Sommer SS
Genome Res; 1997 Apr; 7(4):389-98. PubMed ID: 9110178
[TBL] [Abstract][Full Text] [Related]
9. PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms.
Bottema CD; Sommer SS
Mutat Res; 1993 Jul; 288(1):93-102. PubMed ID: 7686270
[TBL] [Abstract][Full Text] [Related]
10. Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.
Zhu S; Wang J; Zellmer L; Xu N; Liu M; Hu Y; Ma H; Deng F; Yang W; Liao DJ
J Cancer; 2022; 13(9):2810-2843. PubMed ID: 35912015
[TBL] [Abstract][Full Text] [Related]
11. Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
Dou X; Tong P; Huang H; Zellmer L; He Y; Jia Q; Zhang D; Peng J; Wang C; Xu N; Liao DJ
J Cancer; 2020; 11(10):2887-2920. PubMed ID: 32226506
[TBL] [Abstract][Full Text] [Related]
12. Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations.
Zhang J; Lou X; Zellmer L; Liu S; Xu N; Liao DJ
Oncoscience; 2014; 1(9):580-90. PubMed ID: 25594068
[TBL] [Abstract][Full Text] [Related]
13. The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.
Lou X; Zhang J; Liu S; Xu N; Liao DJ
Cell Cycle; 2014; 13(11):1677-93. PubMed ID: 24799665
[TBL] [Abstract][Full Text] [Related]
14. Point mutation instability (PIN) mutator phenotype as model for true back mutations seen in hereditary tyrosinemia type 1 - a hypothesis.
van Dyk E; Pretorius PJ
J Inherit Metab Dis; 2012 May; 35(3):407-11. PubMed ID: 22002443
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059
[TBL] [Abstract][Full Text] [Related]
16. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
17. Direct sequencing of FAH gene in Pakistani tyrosinemia type 1 families reveals a novel mutation.
Ijaz S; Zahoor MY; Imran M; Afzal S; Bhinder MA; Ullah I; Cheema HA; Ramzan K; Shehzad W
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):327-32. PubMed ID: 26565546
[TBL] [Abstract][Full Text] [Related]
18. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.
Jorquera R; Tanguay RM
Hum Mol Genet; 2001 Aug; 10(17):1741-52. PubMed ID: 11532983
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.
Morrow G; Tanguay RM
Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
